Date: 17 April 2024
Time: 10:00 – 15:00
Location: Frauenbad Heidelberg, Berghelmer Str. 45, 69115 Heidelberg, Germany
T Cells and Antigen-Specificity | 2nd Heidelberg Symposium
Applications in Infectious Disease and Immuno-Oncology
In April, Immudex will be hosting a symposium in Heidelberg where researchers from the area will give presentations about their research in the area of antigen-specific immune monitoring of T cells.
This event is free to attend but the number of places is limited so please register to secure your seat.
Program
| 9:30-10:00 |
Morning coffee/tea |
| 10:00-10:30 |
Dr. Michael Delacher, Group Leader, Institute of Immunology Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg-University Main T cells and their role in tissue remodeling and regeneration |
| 10:30-11:00 |
Dr. Isabel Poschke, Head of Immune Monitoring Unit. German Cancer Research Center (DKFZ), Heidelberg Next-generation immune monitoring in immuno-oncology trials – repertoires, receptors, reactivities |
| 11:00-11:30 |
Dr. Ignazio Caruana, Group Leader, University Hospital of Würzburg TBD |
| 11:30-12:00 |
Dr. Jonas Becker, Division of Immunotherapy and Immunoprevention (Prof. Angelika Riemer's Lab), DKFZ The importance of being presented: T cell epitope identification by mass spectrometry-based immunopeptidomics |
|
12:00-13:00 |
Lunch & Get Together |
| 13:00-13:30 |
Dr. Kilian Schober, Group Leader, Erlangen University Hospital Identification and characterization of human antigen-specific T cells |
| 13:30-14:00 |
Dr. Thomas Holberg Blicher, Senior Scientist, Immudex TCR Discovery and Validation |
| 14:00-14:30 |
Dr. Alena Reguzova, Senior Scientist, Prof. Ralf Amann’s Lab, University of Tübingen Advancing next-generation multi-antigen vaccine concepts with a novel Orf virus-based platform |
| 14:30-14:45 |
Dr. Mohammad Salem, Senior Pharma Business & Solution Manager, Immudex Artificial Antigen-Presenting Scaffolds: A Tailored Approach for T-Cell Stimulation and Expansion |
|
Networking |
Meet the Team
Mohammad Salem, PhD
Senior Pharma Business & Solution Manager
Thomas Holberg Blicher, PhD
Senior Scientist